The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma

Annals of Surgical Oncology

Volumn 17, Issue 3, 2010, Pages 791-803

  Solomon, Naveenraj ^a   Zhuge, Ying ^a   Cheung, Michael ^a   Franceschi, Dido ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; LONG TERM CARE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; SURVIVAL RATE;

EID: 77149162024     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0819-4     Document Type: Article

References (52)

1. American Cancer Society. Cancer facts and figures; 2008.
2. CR Baquet P Commiskey K Mack, et al. 2005 Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology J Natl Med Assoc 97 11 1471 1478 16334494
3. WJ Blot SS Devesa RW Kneller JF Fraumeni Jr 1991 Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 10 1287 1289 10.1001/jama.265.10.1287 1:STN:280:DyaK3M7ktVOqsQ%3D%3D 1995976
4. WJ Blot JK McLaughlin 1999 The changing epidemiology of esophageal cancer Semin Oncol 26 5 Suppl 15 2 8 1:STN:280:DC%2BD3c%2FjtVyrsg%3D%3D 10566604
5. N Chalasani JM Wo JP Waring 1998 Racial differences in the histology, location, and risk factors of esophageal cancer J Clin Gastroenterol 26 1 11 13 10.1097/00004836-199801000-00004 1:STN:280:DyaK1c7ltlyltQ%3D%3D 9492855 (Pubitemid 28076814)
6. SS Devesa WJ Blot JF Fraumeni Jr 1998 Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 10 2049 2053 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2 1:STN:280:DyaK1M%2FktlCjuw%3D%3D 9827707 (Pubitemid 28525384)
7. AJ Greenstein VR Litle SJ Swanson, et al. 2008 Racial disparities in esophageal cancer treatment and outcomes Ann Surg Oncol 15 3 881 888 10.1245/s10434-007-9664-5 17987341
8. M Younes DE Henson A Ertan CC Miller 2002 Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type Scand J Gastroenterol 37 12 1359 1365 10.1080/ 003655202762671215 1:STN:280:DC%2BD3s%2Fhs1Oquw%3D%3D 12523583 (Pubitemid 36051495)
9. TN Walsh N Noonan D Hollywood, et al. 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 7 462 467 10.1056/NEJM199608153350702 1:STN:280:DyaK283psF2juw%3D%3D 8672151 (Pubitemid 26269945)
10. V Gebski B Burmeister BM Smithers, et al. 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 3 226 234 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D 17329193 (Pubitemid 46291702)
11. J Tepper MJ Krasna D Niedzwiecki, et al. 2008 Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 7 1086 1092 10.1200/JCO.2007.12.9593 1:CAS:528:DC%2BD1cXktVKitr0%3D 18309943
12. AJ Greenstein VR Litle SJ Swanson, et al. 2008 Prognostic significance of the number of lymph node metastases in esophageal cancer J Am Coll Surg 206 2 239 246 10.1016/j.jamcollsurg.2007.09.003 18222375
13. C Mariette G Piessen N Briez JP Triboulet 2008 The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 2 365 371 10.1097/SLA.0b013e31815aaadf 18216546 (Pubitemid 351156783)
14. Fritz A. International classification of diseases for oncology: ICD-O. 3rd ed. Geneva: World Health Organization; 2000.
15. JA Ajani R Komaki JB Putnam, et al. 2001 A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction Cancer 92 2 279 286 10.1002/1097-0142(20010715)92:2<279::AID-CNCR1320>3.0. CO;2-2 1:CAS:528:DC%2BD3MXlvVynu7k%3D 11466680 (Pubitemid 32664433)
16. S Apisarnthanarax JE Tepper 2008 Crossroads in the combined-modality management of gastroesophageal junction carcinomas Gastrointest Cancer Res 2 5 235 243 19259307
17. NK Altorki XK Zhou B Stiles, et al. 2008 Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2 221 226 10.1097/SLA.0b013e31817bbe59 18650631
18. N Rizk E Venkatraman B Park, et al. 2006 The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system J Thorac Cardiovasc Surg 132 6 1374 1381 10.1016/j.jtcvs.2006.07.039 17140960 (Pubitemid 44820247)
19. CG Peyre JA Hagen SR DeMeester, et al. 2008 The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 4 549 556 18936567
20. JM Donahue FC Nichols Z Li, et al. 2009 Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival Ann Thorac Surg 87 2 392 398 10.1016/j.athoracsur.2008.11.001 19161745 discussion 398-9
21. AL Schwer A Ballonoff R McCammon, et al. 2009 Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a Surveillance, Epidemiology, and End-Results study Int J Radiat Oncol Biol Phys 73 2 499 455
22. SC Malaisrie B Untch GV Aranha, et al. 2004 Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution Arch Surg 139 5 532 538 10.1001/archsurg.139.5.532 15136354 discussion 538-9 (Pubitemid 38585753)
23. GY Ku DH Ilson 2008 Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction Expert Rev Anticancer Ther 8 12 1953 1964 10.1586/14737140.8.12.1953 19046115
24. AC Berger J Farma WJ Scott, et al. 2005 Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 19 4330 4337 10.1200/JCO.2005.05.017 15781882 (Pubitemid 46207006)
25. T Lerut P Nafteux J Moons, et al. 2004 Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma Ann Surg 240 6 962 972 10.1097/01.sla.0000145925.70409.d7 1:STN:280:DC%2BD2cnhvF2qsw%3D%3D 15570202 discussion 972-4 (Pubitemid 39602124)
26. C van de Ven P De Leyn W Coosemans, et al. 1999 Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction Eur J Cardiothorac Surg 15 6 769 773 10.1016/S1010-7940(99)00122-0 10431857 (Pubitemid 29331950)
27. AJ Greenstein VR Litle SJ Swanson, et al. 2008 Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer 112 6 1239 1246 10.1002/cncr.23309 18224663
28. CH Kang YT Kim SH Jeon, et al. 2007 Lymphadenectomy extent is closely related to long-term survival in esophageal cancer Eur J Cardiothorac Surg 31 2 154 160 10.1016/j.ejcts.2006.10.033 17145185 (Pubitemid 46157270)
29. American Joint Committee on Cancer. AJCC cancer staging manual. Philadelphia: Lippincott-Raven; 1997. p. 65-9.
30. AC Chang H Ji NJ Birkmeyer, et al. 2008 Outcomes after transhiatal and transthoracic esophagectomy for cancer Ann Thorac Surg 85 2 424 429 10.1016/j.athoracsur.2007.10.007 18222237
31. MJ Boyle D Franceschi AS Livingstone 1999 Transhiatal versus transthoracic esophagectomy: complication and survival rates Am Surg 65 12 1137 1141 1:STN:280:DC%2BD3c%2Fmt1WqtQ%3D%3D 10597061 discussion 1141-2
32. JB Hulscher JW van Sandick AG de Boer, et al. 2002 Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 21 1662 1669 10.1056/NEJMoa022343 12444180 (Pubitemid 35340784)
33. J Johansson TR DeMeester JA Hagen, et al. 2004 En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus Arch Surg 139 6 627 631 10.1001/archsurg.139.6.627 15197089 discussion 631-3 (Pubitemid 38725071)
34. WT Vigneswaran VF Trastek PC Pairolero, et al. 1993 Transhiatal esophagectomy for carcinoma of the esophagus Ann Thorac Surg 56 4 838 844 1:STN:280:DyaK2c%2FivFansQ%3D%3D 8215660 discussion 844-6
35. JM Omloo SY Law B Launois, et al. 2009 Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection Eur J Surg Oncol 35 8 793 797 1:STN:280:DC%2BD1Mvks1aitA%3D%3D 19010634
36. L Gluch RC Smith CP Bambach AR Brown 1999 Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma World J Surg 23 3 271 275 10.1007/PL00013184 1:STN:280:DyaK1M7jsVCqsw%3D%3D 9933699 discussion 275-6 (Pubitemid 29091697)
37. O Horstmann PR Verreet H Becker, et al. 1995 Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer Eur J Surg 161 8 557 567 1:STN:280: DyaK28%2FlsFamtQ%3D%3D 8519871
38. J Rentz D Bull D Harpole, et al. 2003 Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients J Thorac Cardiovasc Surg 125 5 1114 1120 10.1067/mtc.2003.315 12771885 (Pubitemid 36644889)
39. R Rindani CJ Martin MR Cox 1999 Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust N Z J Surg 69 3 187 194 10.1046/j.1440-1622.1999.01520.x 1:STN:280:DyaK1M7ntlKkuw%3D%3D 10075357 (Pubitemid 29111258)
40. RC Connors BC Reuben LA Neumayer DA Bull 2007 Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17, 395 patients J Am Coll Surg 205 6 735 740 10.1016/j.jamcollsurg.2007.07.001 18035255 (Pubitemid 350116630)
41. Surveillance, Epidemiology and End Results (SEER) Program. National Cancer Institute; 2005.
42. MC Cheung EA Perez MA Molina, et al. 2008 Defining the role of surgery for primary gastrointestinal tract melanoma J Gastrointest Surg 12 4 731 738 10.1007/s11605-007-0417-3 18058185
43. Gutierrez JC, De Oliveira LO, Perez EA, et al. Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors. J Am Coll Surg. 2007;205(3):479-91 (Quiz 524).
44. JC Gutierrez AC Fischer JE Sola, et al. 2007 Markedly improving survival of neuroblastoma: a 30-year analysis of 1, 646 patients Pediatr Surg Int 23 7 637 646 10.1007/s00383-007-1933-7 17476512 (Pubitemid 47013583)
45. JC Gutierrez D Franceschi LG Koniaris 2008 How many lymph nodes properly stage a periampullary malignancy? J Gastrointest Surg 12 1 77 85 10.1007/s11605-007-0251-7 17701264
46. JC Gutierrez N Housri LG Koniaris, et al. 2008 Malignant breast cancer in children: a review of 75 patients J Surg Res 147 2 182 188 10.1016/j.jss.2008. 03.026 18498867
47. N Hodgson LG Koniaris AS Livingstone D Franceschi 2005 Gastric carcinoids: a temporal increase with proton pump introduction Surg Endosc 19 12 1610 1612 10.1007/s00464-005-0232-4 1:STN:280:DC%2BD2MnivVWjtg%3D%3D 16211437 (Pubitemid 41719529)
48. EA Perez JC Gutierrez X Jin, et al. 2007 Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination J Gastrointest Surg 11 1 114 125 10.1007/s11605-006-0072-0 17390197
49. EA Perez AS Livingstone D Franceschi, et al. 2006 Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors J Am Coll Surg 202 4 623 629 10.1016/j.jamcollsurg.2006.01.002 16571433
50. T Kircher J Nelson H Burdo 1985 The autopsy as a measure of accuracy of the death certificate N Engl J Med 313 20 1263 1269 1:STN:280: DyaL28%2FktVansA%3D%3D 4058507
51. AE Smith Sehdev GM Hutchins 2001 Problems with proper completion and accuracy of the cause-of-death statement Arch Intern Med 161 2 277 284 10.1001/archinte.161.2.277 1:STN:280:DC%2BD3M7mt1aqtw%3D%3D 11176744
52. NG Coburn A Govindarajan CH Law, et al. 2008 Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4, 041 patients Ann Surg Oncol 15 2 500 507 10.1245/s10434-007-9640-0 18026800